Warner Chilcott Overview
- Year Founded
-
1968
- Status
-
Acquired/Merged
- Employees
-
2,100
- Latest Deal Type
-
M&A
- Financing Rounds
-
19
- Investments
-
2
Warner Chilcott General Information
Description
Manufacturer of pharmaceutical products for the women's healthcare and dermatology segments. The company focuses on the gastroenterology, women's healthcare, dermatology and urology segments.
Contact Information
Website
www.wcrx.comCorporate Office
- 1 Grand Canal Square
- Docklands
- Dublin 2
- Ireland
Corporate Office
- 1 Grand Canal Square
- Docklands
- Dublin 2
- Ireland
Warner Chilcott Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Warner Chilcott Comparisons
Industry
Financing
Details
Warner Chilcott Competitors (7)
One of Warner Chilcott’s 7 competitors is Takeda Pharmaceutical, a Corporation company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical | Corporation | Tokyo, Japan | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Taro Pharmaceutical Industries | Corporate Backed or Acquired | Haifa Bay, Israel | ||||
| GSK | Corporation | Middlesex, United Kingdom |
Warner Chilcott Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Warner Chilcott Patents
Warner Chilcott Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2953619-A1 | Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability | Inactive | 15-Mar-2013 | ||
| JP-6294457-B2 | Mesalamine pharmaceutical composition comprising multiple dosing elements for reduced delivery variability | Inactive | 15-Mar-2013 | ||
| ES-2619121-T3 | Dosage dosage form in soft gelatin capsule with modified guar gum | Active | 15-Mar-2013 | ||
| JP-2020147569-A | Pharmaceutical soft gelatin capsule dosage form with modified guar gum | Pending | 15-Mar-2013 | ||
| JP-2016513693-A | Mesalamine pharmaceutical composition comprising multiple dosing elements for reduced delivery variability | Active | 15-Mar-2013 | A61K9/2846 |
Warner Chilcott Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Warner Chilcott Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Warner Chilcott Investments (2)
Warner Chilcott’s most recent deal was a Buyout/LBO with Procter & Gamble (Prescription Drug Business) for . The deal was made on 30-Oct-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Procter & Gamble (Prescription Drug Business) | 30-Oct-2009 | Buyout/LBO | Pharmaceuticals | ||
| Bristol-Myers Squibb (3 products) | 16-Feb-2000 | Corporate Asset Purchase | Buildings and Property |
Warner Chilcott FAQs
-
When was Warner Chilcott founded?
Warner Chilcott was founded in 1968.
-
Where is Warner Chilcott headquartered?
Warner Chilcott is headquartered in Dublin, Ireland.
-
What is the size of Warner Chilcott?
Warner Chilcott has 2,100 total employees.
-
What industry is Warner Chilcott in?
Warner Chilcott’s primary industry is Pharmaceuticals.
-
Is Warner Chilcott a private or public company?
Warner Chilcott is a Private company.
-
What is the current valuation of Warner Chilcott?
The current valuation of Warner Chilcott is .
-
What is Warner Chilcott’s current revenue?
The current revenue for Warner Chilcott is .
-
How much funding has Warner Chilcott raised over time?
Warner Chilcott has raised $6.2B.
-
Who are Warner Chilcott’s investors?
AlpInvest Partners, Avista Healthcare Partners, Bain Capital, Banexi Ventures Partners, and CCMP Capital Advisors are 5 of 12 investors who have invested in Warner Chilcott.
-
Who are Warner Chilcott’s competitors?
Takeda Pharmaceutical, AstraZeneca, Novartis, Taro Pharmaceutical Industries, and GSK are some of the 7 competitors of Warner Chilcott.
-
When was Warner Chilcott acquired?
Warner Chilcott was acquired on 01-Oct-2013.
-
Who acquired Warner Chilcott?
Warner Chilcott was acquired by Allergan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
